GPLB on OTC
Green Planet Bio Engineering Co. Ltd.
Biological products company, listed on OTC (GPLB)1
In its 2026 annual report the company says: “Green Planet Bioengineering Co., Ltd. operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation. The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation.”3 It is headquartered in Aventura, Florida.1
Price unavailable
Last updated Oct 21, 2026.
Overview
- TickerGPLB on OTC1
- IndustryBiological Products, (No Diagnostic Substances)1
- HeadquartersAventura, Florida1
- Business address20807 Biscayne Blvd., Suite 203, Aventura, Fl 331802
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Green Planet Bioengineering Co., Ltd. (“Green Planet” or “Company”) operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Administrative expenses | -$35.8K | -$35.5K |
| Interest expenses | $0 | $0 |
| Loss before income taxes | -$35.8K | -$35.5K |
| Provision for income taxes | $0 | $0 |
| Net Loss | -$35.8K | -$35.5K |
| -Basic and diluted | $0.00 | $0.00 |
| -Basic and diluted | 20.0M shares | 20.0M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.9
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $0 | $0 | $0 |
| TOTAL CURRENT ASSETS | $0 | $0 | |
| Accounts payable and accrued liabilities | $16.3K | $5.5K | |
| Amount due to a related party | $484.7K | $459.6K | |
| TOTAL CURRENT LIABILITIES | $501.0K | $465.1K | |
| Preferred stock : par value of $0.001 per share, Authorized: 10,000,000 shares at December 31, 2025 and December 31, 2024Issued and outstanding : 0 shares at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock : par value $0.001 per share Authorized : 250,000,000 shares at December 31, 2025 and December 31, 2024 Issued and outstanding : 20,006,402 shares at December 31, 2025 and December 31, 2024 | $20.0K | $20.0K | |
| Additional paid-in capital | $609.6K | $609.6K | |
| Accumulated deficit | -$1.1M | -$1.1M | |
| TOTAL STOCKHOLDERS' DEFICIT | -$501.0K | -$465.1K | -$429.6K |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $0 | $0 | |
| Preferred Stock, Par Value | $0.00 | $0.00 | |
| Preferred Stock, Authorized | 10.0M shares | 10.0M shares | |
| Preferred Stock, Issued | 0 shares | 0 shares | |
| Preferred Stock, Outstanding | 0 shares | 0 shares | |
| Common Stock, Par Value | $0.00 | $0.00 | |
| Common Stock, Authorized | 250.0M shares | 250.0M shares | |
| Common Stock, Issued | 20.0M shares | 20.0M shares | |
| Common Stock, Outstanding | 20.0M shares | 20.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $0 | $0 | $0 |
| TOTAL CURRENT ASSETS | $0 | $0 | |
| Accounts payable and accrued liabilities | $16.3K | $5.5K | |
| Amount due to a related party | $484.7K | $459.6K | |
| TOTAL CURRENT LIABILITIES | $501.0K | $465.1K | |
| Preferred stock : par value of $0.001 per share, Authorized: 10,000,000 shares at December 31, 2025 and December 31, 2024Issued and outstanding : 0 shares at December 31, 2025 and December 31, 2024 | $0 | $0 | |
| Common stock : par value $0.001 per share Authorized : 250,000,000 shares at December 31, 2025 and December 31, 2024 Issued and outstanding : 20,006,402 shares at December 31, 2025 and December 31, 2024 | $20.0K | $20.0K | |
| Additional paid-in capital | $609.6K | $609.6K | |
| Accumulated deficit | -$1.1M | -$1.1M | |
| TOTAL STOCKHOLDERS' DEFICIT | -$501.0K | -$465.1K | -$429.6K |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $0 | $0 | |
| Preferred Stock, Par Value | $0.00 | $0.00 | |
| Preferred Stock, Authorized | 10.0M shares | 10.0M shares | |
| Preferred Stock, Issued | 0 shares | 0 shares | |
| Preferred Stock, Outstanding | 0 shares | 0 shares | |
| Common Stock, Par Value | $0.00 | $0.00 | |
| Common Stock, Authorized | 250.0M shares | 250.0M shares | |
| Common Stock, Issued | 20.0M shares | 20.0M shares | |
| Common Stock, Outstanding | 20.0M shares | 20.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.9
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$35.8K | -$35.5K |
| Accounts payable and accrued liabilities | -$702 | $500 |
| Net cash flows used by operating activities | -$36.5K | -$35.0K |
| Amount due to a related company | $36.5K | $35.0K |
| Cash flows provided by financing activities | $36.5K | $35.0K |
| Net change in cash | $0 | $0 |
| Cash paid for interest | $0 | $0 |
| Cash paid for income taxes | $0 | $0 |
No quarter-by-quarter statement was filed.
Compare Green Planet Bio Engineering Co. Ltd. with another company
Leadership
Who has led Green Planet Bio Engineering Co. Ltd., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerMin Zhao Nov 5, 2008 to Nov 5, 200812
- PresidentCris Neely Oct 24, 2008 to Oct 24, 200813
- PresidentDarrin M. Ocasio Jul 17, 2007 to Jul 17, 200714
Board members and other officers (8)
- VP of SalesShanyan Ou Dec 17, 2008 to Dec 17, 200815
- SecretaryMichael H. Ference Jul 17, 2007 to Jul 17, 200716
- Board memberCris Neely Oct 24, 2008 to Oct 24, 200813
- Board memberJianrong Zheng Dec 17, 2008 to Dec 17, 200817
- Board memberShanyan Ou Dec 17, 2008 to Dec 17, 200815
- Board memberGregory Sichenzia Jul 13, 2007 to Jul 13, 200718
- Board memberDarrin M. Ocasio Jul 17, 2007 to Jul 17, 200714
- Board memberMichael H. Ference Jul 17, 2007 to Jul 17, 200716
Former names
- Mondo Acquisition II, Inc.May 2, 2007 to Oct 9, 20082
Timeline
Filings
22 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 2 major events. The latest 20:
- Aug 13, 202610-Q EDGAR
- May 15, 202610-Q EDGAR
- Mar 31, 202610-K EDGAR
- Nov 14, 202510-Q EDGAR
- Aug 8, 202510-Q EDGAR
- May 15, 202510-Q EDGAR
- May 15, 20258-K EDGAR
- Mar 7, 202510-K EDGAR
- Nov 14, 202410-Q EDGAR
- Aug 14, 202410-Q EDGAR
- May 9, 202410-Q EDGAR
- Mar 29, 202410-K EDGAR
- Nov 9, 202310-Q EDGAR
- Aug 10, 202310-Q EDGAR
- May 12, 202310-Q EDGAR
- Mar 30, 202310-K EDGAR
- Nov 14, 202210-Q EDGAR
- Oct 14, 20228-K EDGAR
- Aug 9, 202210-Q EDGAR
- May 13, 202210-Q EDGAR
The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Green Planet Bio Engineering Co. Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARGreen Planet Bio Engineering Co. Ltd.1
- CIK0001392449
- Employer ID (EIN)37-15328423
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company3
- Incorporated inDelaware3
- Fiscal year endsDecember 311
- Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address20807 Biscayne Blvd., Suite 203, Aventura, FL 331801
- Phone786-279-29001
- Shares outstanding20,006,402 as of Aug 13, 202611
- Public float$26.3K as of Jun 30, 20253
- AuditorStephano Slack LLC, Wayne, Pennsylvania PCAOB ID 35233
- On EDGAR sinceMay 2, 20071
- Filings154 in all: 10-Q (56), 10-K (18), 8-K (15), UPLOAD (13), 3 (10), CORRESP (6), NT 10-K (6), NT 10-Q (6)1
All 19 form types
8-K/A (5), PRER14C (3), SC 13D (3), SC 14F1 (3), 10QSB (2), DEF 14C (2), PRE 14C (2), 10KSB (1), 10SB12G (1), 4 (1), S-8 (1)
- Latest filingsAnnual report (10-K) Mar 31, 2026
Quarterly report (10-Q) Aug 13, 2026
Latest 8-K (8-K) May 15, 2025
Risk factors and legal proceedings
The risks Green Planet Bio Engineering Co. Ltd. names in Item 1A of its 10-K filed Mar 31, 2026: 4 risks under these headings, as written.3
- Risk Related to the Company's Future Business
- We give no assurances that any plans for future business will be implemented if we do not secure adequate financing or find profitable business opportunities.
- We will continue to incur significant costs as a result of remaining as a public reorganized company, and management will be required to devote substantial time to new compliance requirements.
- Risks Related to the Common Stock
- There is currently no trading market for our common stock.
- We have not paid and do not anticipate paying any dividends on our common stock; therefore, our securities could face devaluation in the market.
- Penny Stock Regulations
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARMin Zhao, Chief executive officer
- 13SEC EDGARCris Neely, President
- 14SEC EDGARDarrin M. Ocasio, President
- 15SEC EDGARShanyan Ou, VP of Sales
- 16SEC EDGARMichael H. Ference, Secretary
- 17SEC EDGARJianrong Zheng, Board member
- 18SEC EDGARGregory Sichenzia, Board member
- 19SEC EDGARChange of auditor
- 20SEC EDGARChange of auditor